We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance Offers Flexibility for Compounding Liquid Ibuprofen
FDA Guidance Offers Flexibility for Compounding Liquid Ibuprofen
In response to record high demand for ibuprofen oral suspension products, the FDA has issued an immediately-in-effect guidance allowing the products to be compounded in outsourcing facilities for use in hospitals and health systems.